Deutsche Bank AG Has $3.61 Million Stock Holdings in Amedisys, Inc. $AMED

Key Points

• Deutsche Bank AG significantly increased its stake in Amedisys, Inc. by 1,441.8% during the first quarter, acquiring a total of 38,916 shares valued at approximately $3.61 million.
• Amedisys reported a net margin of 3.56% and a revenue increase of 5.2% year-over-year, with earnings of $1.54 per share for the last quarter, exceeding analyst expectations.
• Wall Street analysts downgraded Amedisys from a "strong-buy" rating to a "buy" rating recently, reflecting a shift in market sentiment.

Deutsche Bank AG lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1,441.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 38,916 shares of the health services provider's stock after acquiring an additional 36,392 shares during the quarter. Deutsche Bank AG owned approximately 0.12% of Amedisys worth $3,605,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Hexagon Capital Partners LLC raised its holdings in Amedisys by 108.1% in the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after acquiring an additional 161 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after buying an additional 120 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock worth $32,000 after buying an additional 141 shares in the last quarter. UMB Bank n.a. grew its position in Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after acquiring an additional 193 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in Amedisys during the 4th quarter worth $55,000. 94.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Wall Street Zen lowered Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $100.50.

Amedisys Trading Up 0.0%

Shares of AMED stock traded up $0.03 on Friday, hitting $101.01. The company had a trading volume of 1,060,057 shares, compared to its average volume of 780,222. The firm has a market cap of $3.32 billion, a P/E ratio of 39.30, a P/E/G ratio of 1.34 and a beta of 0.89. The stock's 50-day moving average is $98.47 and its two-hundred day moving average is $95.04. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.36 and a current ratio of 1.36. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $101.02.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.15. The company had revenue of $621.86 million during the quarter, compared to analysts' expectations of $614.61 million. Amedisys had a return on equity of 12.91% and a net margin of 3.56%.The business's quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 earnings per share. On average, equities research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.